Opko Health OPK
NASDAQ OPK
$1.73 +0.04 (+2.41%)
As of: Sep 22, 2026 · 10:07 AM EDT

Opko Health (OPK) Non Operating Investment Income (2010 - 2013)

Opko Health's (OPK) quarterly Non Operating Investment Income came in at -$2.4 million in Q2 2013, down 399.16% on a YoY basis from $792558.1 in Q2 2012, and up 39.05% quarter-over-quarter from -$3.9 million in Q1 2013.

Analysis

Opko Health (OPK) Non Operating Investment Income (2010 - 2013) Analysis & Trends

Opko Health (OPK) has reported Non Operating Investment Income for 4 consecutive years, with -$2.4 million the latest figure, recorded in Q2 2013.

  • For the quarter ending Q2 2013, Non Operating Investment Income fell 399.16% year-over-year to -$2.4 million; the trailing twelve-month figure through Jun 2013 stood at -$7.3 million (down 327.73% YoY), and the FY2012 full-year result was -$2.1 million, down 29.77% from the prior year.
  • Non Operating Investment Income climbed to -$2.4 million in Q2 2013 per OPK's latest filing, from -$3.9 million in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at -$31000.0 in Q4 2010 and bottomed at -$3.9 million in Q1 2013.
  • Historically, Non Operating Investment Income has averaged -$799769.2 across 4 years, with a median of -$451000.0 in 2011.
  • The sharpest annual moves came in 2011 and 2012: Non Operating Investment Income sank 1235.48% in 2011, then slipped 5.32% in 2012.
  • Over 4 years, Non Operating Investment Income stood at -$31000.0 in 2010, then tumbled by 1235.48% to -$414000.0 in 2011, then tumbled by 44.44% to -$598000.0 in 2012, then sank by 296.49% to -$2.4 million in 2013.
  • According to Business Quant data, Non Operating Investment Income over the past three periods registered -$2.4 million, -$3.9 million, and -$598000.0 for Q2 2013, Q1 2013, and Q4 2012 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 -2.37 Mn
Mar 31, 2013 -3.89 Mn
Dec 31, 2012 -598,000.00
Sep 30, 2012 -468,000.00
Jun 30, 2012 -475,000.00
Mar 31, 2012 -523,000.00
Dec 31, 2011 -414,000.00
Sep 30, 2011 -301,000.00
Jun 30, 2011 -451,000.00
Mar 31, 2011 -423,000.00
Dec 31, 2010 -31,000.00
Sep 30, 2010 -208,000.00
Jun 30, 2010 -244,000.00
API Access

Opko Health Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=OPK&period=max&api_key=YOUR_API_KEY